These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 18191574)

  • 1. Differences in improvement between patients with idiopathic versus neurovascular hemifacial spasm after botulinum toxin treatment.
    Tunç T; Cavdar L; Karadağ YS; Okuyucu E; Coşkun O; Inan LE
    J Clin Neurosci; 2008 Mar; 15(3):253-6. PubMed ID: 18191574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemifacial spasm and its treatment with botulinum toxin].
    Gouider-Khouja N; Turki I; Ben Hamida M; Hentati F
    Tunis Med; 1999 Jan; 77(1):41-4. PubMed ID: 10333697
    [No Abstract]   [Full Text] [Related]  

  • 3. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM; Carelli EF; Viana MA
    Clin Neuropharmacol; 2010; 33(1):27-31. PubMed ID: 20124784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30).
    Tan EK; Fook-Chong S; Lum SY; Lim E
    J Neurol Sci; 2004 Apr; 219(1-2):151-5. PubMed ID: 15050451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcome correlates with knowledge of disease in hemifacial spasm.
    Tan EK; Hameed S; Fook-Chong S; Hussein K; Lum SY; Chan LL
    Clin Neurol Neurosurg; 2008 Sep; 110(8):813-7. PubMed ID: 18583029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for neurological disorders in a movement disorders clinic in Singapore.
    Tan AK
    Singapore Med J; 1998 Sep; 39(9):403-5. PubMed ID: 9885719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hemifacial spasm with botulinum toxin.
    Yoshimura DM; Aminoff MJ; Tami TA; Scott AB
    Muscle Nerve; 1992 Sep; 15(9):1045-9. PubMed ID: 1518513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Babinski-2 sign in hemifacial spasm.
    Pawlowski M; Gess B; Evers S
    Mov Disord; 2013 Aug; 28(9):1298-300. PubMed ID: 23637014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm.
    Setthawatcharawanich S; Aui-aree N; Limapichart K; Satirapunya P; Phabphal K
    J Med Assoc Thai; 2008 Nov; 91(11):1691-7. PubMed ID: 19127791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm.
    Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T
    Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemifacial spasm: over 10 years of treatment with botulinum toxin].
    Pérez-Saldaña MT; Parkhutik V; Boscá-Blasco ME; Claramonte B; Burguera-Hernández JA
    Rev Neurol; 2007 Nov 16-30; 45(10):582-6. PubMed ID: 18008262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blepharospasm and hemifacial spasm: a protocol for titration of botulinum toxin dose to the individual patient and for the management of refractory cases.
    Ortisi E; Henderson HW; Bunce C; Xing W; Collin JR
    Eye (Lond); 2006 Aug; 20(8):916-22. PubMed ID: 16531977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm].
    Burbaud P; Arnaud A; Burbaud A; Lagueny A
    J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced facial nerve hyperexcitability from contralateral cerebral stroke in hemifacial spasm.
    Kumar KR; Ng K
    Mov Disord; 2010 Jul; 25(9):1310-2. PubMed ID: 20310047
    [No Abstract]   [Full Text] [Related]  

  • 15. Quality of life in hemifacial spasm patient after treatment with botulinum toxin A; a 24-week, double-blind, randomized, cross-over comparison of Dysport and Neuronox study.
    Kongsengdao S; Kritalukkul S
    J Med Assoc Thai; 2012 Mar; 95 Suppl 3():S48-54. PubMed ID: 22619887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin in the treatment of blepharospasm and hemifacial spasm.
    Kenney C; Jankovic J
    J Neural Transm (Vienna); 2008; 115(4):585-91. PubMed ID: 17558461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin-A for the treatment of hemifacial spasm.
    Cuevas C; Madrazo I; Magallón E; Zamorano C; Neri G; Reyes E
    Arch Med Res; 1995; 26(4):405-8. PubMed ID: 8555735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm.
    Rieder CR; Schestatsky P; Socal MP; Monte TL; Fricke D; Costa J; Picon PD
    Clin Neuropharmacol; 2007; 30(1):39-42. PubMed ID: 17272968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectivity of Dysport in patients with blepharospasm and hemifacial spasm who experienced failure with Botox.
    Badarny S; Susel Z; Honigman S
    Isr Med Assoc J; 2008 Jul; 10(7):520-2. PubMed ID: 18751631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial hypertension in patients with left primary hemifacial spasm is associated with neurovascular compression of the left rostral ventrolateral medulla.
    Nakamura T; Osawa M; Uchiyama S; Iwata M
    Eur Neurol; 2007; 57(3):150-5. PubMed ID: 17213721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.